Colby Souders PhD

Chief Scientific Officer, Biopharma at Twist Bioscience

Speaker

Colby Souders earned his PhD in Cell and Molecular Biology from Texas A&M and previously held positions at BrickBio, Abveris, MassBiologics and Kanyos Bio. At MassBiologics, he worked to advance monoclonal antibodies for the prevention, treatment or diagnosis of various infectious and endogenous diseases, as well as developed related platform technologies to advance and expand the MassBiologics pipeline. Later, he joined the Kanyos Bio Protein Engineering team to develop therapeutics based on a novel antigen-specific immune tolerance platform. Colby has served as Chief Scientific Officer at BrickBio to develop novel antibody drug conjugates and was CSO at Abveris prior to acquisition by Twist Bioscience. He now serves as the CSO of Twist Biopharma to guide the biologics discovery division of Twist.